RSPO Urges for Broader Smallholder Inclusion and Increased Technology Adoption

From smallholder financing, ecosystem regeneration to supply chain innovation, the Roundtable on…

OCBC Launches Tap Credit Card: Seamless NFC Transactions for Speed and Convenience

JAKARTA, Indonesia, Nov. 10, 2025 /PRNewswire/ — PT Bank OCBC NISP Tbk…

Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo

BOSTON, Nov. 10, 2025 /PRNewswire/ — Fapon, a globally leading life sciences…

Bybit Collaborates with Taxbit to Ensure Seamless Financial Compliance for Global and EU Users

DUBAI, UAE, Nov. 10, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…

Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage

NANJING, China, Nov. 10, 2025 /PRNewswire/ — Simcere Pharmaceutical Group (2096.HK) announced…

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ — LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical…

Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech

BEIJING, Nov. 10, 2025 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the…

Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer

HONG KONG, Nov. 10, 2025 /PRNewswire/ — Akeso, Inc. (HKEX: 9926. HK)…